Relationship between Hypogonadal Symptoms, Sexual Dysfunction and Chronic Prostatitis in Middle-Aged Men by Self-Reported Questionnaires, even without Biochemical Testosterone Deficiency.
Erectile dysfunction
Hypogonadism
Premature ejaculation
Prostatitis
Questionnaires
Journal
The world journal of men's health
ISSN: 2287-4208
Titre abrégé: World J Mens Health
Pays: Korea (South)
ID NLM: 101596899
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
18
09
2019
revised:
15
01
2020
accepted:
29
01
2020
entrez:
18
3
2020
pubmed:
18
3
2020
medline:
18
3
2020
Statut:
ppublish
Résumé
To investigate the association of erectile dysfunction (ED), premature ejaculation (PE), and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men with late-onset hypogonadism (LOH). We reviewed the data of 408 enrolled men between January 2014 and January 2019. All participants completed the Androgen Deficiency in the Aging Male (ADAM), international index of erectile function-5 (IIEF-5), National Institutes of Health chronic prostatitis symptom index (NIH-CPSI), and premature ejaculation diagnostic tool (PEDT) questionnaires. Participants were divided by ADAM positive (ADAM+: Group 1) and ADAM negative (ADAM-: Group 2). Total of 289 subjects were in Group 1 and 119 were in Group 2. The mean age was 53.8±7.8 years. The mean total testosterone was 4.8±1.2 ng/dL and showed no differences between the groups (p=0.839). In Groups 1 and 2, ED (IIEF≤21) was identified in 233 (80.6%) versus 37 (31.1%), respectively (p<0.001). The prevalence of PE (PEDT≥9) was 112 (38.7%) versus 13 (10.9%) in Groups 1 and 2, respectively (p<0.001). However, PE (intravaginal ejaculation latency time<5 minutes) showed no differences between the groups (p=0.863). The incidence of chronic prostatitis (NIH-CPSI pain score≥4) showed significant differences with 49 (17.0%) versus 8 (6.7%) in Groups 1 and 2, respectively (p=0.007). IIEF-5 total score showed the significantly highest negative correlation (r=-0.313, p<0.001). Those who complained of LOH symptoms and positive results in the ADAM questionnaire need to be assessed concurrently with the above questionnaires. This could aid useful to detect of ED, PE, and chronic prostatitis co-occurrence.
Identifiants
pubmed: 32180375
pii: 38.243
doi: 10.5534/wjmh.190117
pmc: PMC7076313
doi:
Types de publication
Journal Article
Langues
eng
Pagination
243-249Informations de copyright
Copyright © 2020 Korean Society for Sexual Medicine and Andrology.
Déclaration de conflit d'intérêts
The authors have nothing to disclose.
Références
J Sex Med. 2008 Aug;5(8):1991-8
pubmed: 18399946
Int J Impot Res. 1999 Sep;11 Suppl 1:S60-4
pubmed: 10554933
J Sex Med. 2016 Jul;13(7):1047-55
pubmed: 27235281
J Sex Med. 2012 Feb;9(2):454-65
pubmed: 22023395
J Sex Med. 2014 Jun;11(6):1512-8
pubmed: 24528521
JAMA. 2006 Apr 5;295(13):1549-55
pubmed: 16595758
Urology. 2002 Dec;60(6 Suppl):1-4
pubmed: 12521576
J Clin Endocrinol Metab. 2012 May;97(5):1508-16
pubmed: 22419720
J Sex Res. 2016 Nov-Dec;53(9):1165-1178
pubmed: 27215144
J Androl. 2005 Sep-Oct;26(5):601-3
pubmed: 16088036
World J Urol. 2013 Aug;31(4):741-6
pubmed: 23579441
J Sex Med. 2014 May;11(5):1309-15
pubmed: 24612680
PLoS One. 2016 Apr 27;11(4):e0153054
pubmed: 27120096
BJU Int. 2011 Jul;108(2):256-62
pubmed: 20955266
Arab J Urol. 2015 Sep;13(3):162-8
pubmed: 26413340
J Urol. 2008 May;179(5 Suppl):S61-7
pubmed: 18405756
Urology. 2008 Feb;71(2):261-6
pubmed: 18308097
Int J Clin Exp Med. 2015 Aug 15;8(8):13901-10
pubmed: 26550346
J Urol. 2004 Sep;172(3):839-45
pubmed: 15310980
J Urol. 2009 Dec;182(6 Suppl):S45-50
pubmed: 19846136
World J Urol. 2016 Jul;34(7):1009-17
pubmed: 26546073
Metabolism. 2000 Sep;49(9):1239-42
pubmed: 11016912
BJU Int. 2009 Apr;103 Suppl 3:33-41
pubmed: 19302500
Int J Clin Pract. 2002 Nov;56(9):663-71
pubmed: 12469980
J Urol. 2000 Feb;163(2):460-3
pubmed: 10647654
Andrologia. 2008 Apr;40(2):125-9
pubmed: 18336464
Asian J Androl. 2014 Mar-Apr;16(2):192-202
pubmed: 24407185